← back to search

Onno B. Bleijerveld

Utrecht University · NL
Area of research
Molecular Biology · Spectroscopy
Research interest
Research interests include Biology, Cancer research, Chemistry, Cell biology, Computational biology, and Genetics.
h-index
citations
1,571
works
23
NIH funding
primary concept
email

Recent publications

NASP modulates histone turnover to drive PARP inhibitor resistance
Nature 2025cited by 10position: middledoi
Arginine deprivation enriches lung cancer proteomes with cysteine by inducing arginine-to-cysteine substitutants
Molecular Cell 2024cited by 22position: middledoi
Multimodal stimulation screens reveal unique and shared genes limiting T cell fitness
Cancer Cell 2024cited by 16position: middledoi
MYC is a clinically significant driver of mTOR inhibitor resistance in breast cancer
The Journal of Experimental Medicine 2023cited by 27position: middledoi
Natural deletion of mouse carboxylesterases Ces1c/d/e impacts drug metabolism and metabolic syndrome development
Biomedicine & Pharmacotherapy 2023cited by 13position: middledoi
Ubiquitinome Profiling Reveals in Vivo UBE2D3 Targets and Implicates UBE2D3 in Protein Quality Control
Molecular & Cellular Proteomics 2023cited by 11position: middledoi
Tryptophan depletion results in tryptophan-to-phenylalanine substitutants
Nature 2022cited by 133position: middledoi
Ubiquitin ligase STUB1 destabilizes IFNγ-receptor complex to suppress tumor IFNγ signaling
Nature Communications 2022cited by 53position: middledoi
Oncogene-dependent sloppiness in mRNA translation
Molecular Cell 2021cited by 55position: middledoi
A comprehensive enhancer screen identifies TRAM2 as a key and novel mediator of YAP oncogenesis
Genome biology 2021cited by 24position: middledoi
Anti-tumour immunity induces aberrant peptide presentation in melanoma
Nature 2020cited by 148position: middledoi
Crystal structure of the tubulin tyrosine carboxypeptidase complex VASH1–SVBP
Nature Structural & Molecular Biology 2019cited by 31position: middledoi
Nedd4-Binding Protein 1 and TNFAIP3-Interacting Protein 1 Control MHC-1 Display in Neuroblastoma
Cancer Research 2018cited by 62position: middledoi
Vasohibins encode tubulin detyrosinating activity
Science 2017cited by 272position: middledoi
Genetic wiring maps of single-cell protein states reveal an off-switch for GPCR signalling
Nature 2017cited by 146position: middledoi
Endogenous androgen receptor proteomic profiling reveals genomic subcomplex involved in prostate tumorigenesis
Oncogene 2017cited by 128position: middledoi
H4K20me2 distinguishes pre-replicative from post-replicative chromatin to appropriately direct DNA repair pathway choice by 53BP1-RIF1-MAD2L2
Cell Cycle 2017cited by 47position: middledoi
BRAFV600E Kinase Domain Duplication Identified in Therapy-Refractory Melanoma Patient-Derived Xenografts
Cell Reports 2016cited by 84position: middledoi
Expression and characterization of recombinant chicken mannose binding lectin
Immunobiology 2016cited by 30position: middledoi
Myc coordinates transcription and translation to enhance transformation and suppress invasiveness
EMBO Reports 2015cited by 60position: middledoi
Quantitative proteomics analysis reveals similar release profiles following specific PAR-1 or PAR-4 stimulation of platelets
Cardiovascular Research 2014cited by 76position: middledoi
High Precision Platelet Releasate Definition by Quantitative Reversed Protein Profiling—Brief Report
Arteriosclerosis Thrombosis and Vascular Biology 2013cited by 98position: middledoi
Imatinib-dependent tyrosine phosphorylation profiling of Bcr-Abl-positive chronic myeloid leukemia cells
Leukemia 2012cited by 25position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Maarten Altelaar · Utrecht University15 papers (2015–2023)Reuven Agami · University of Michigan–Ann Arbor6 papers (2015–2024)Daniel S. Peeper · Dutch Cancer Society4 papers (2016–2022)Thijn R. Brummelkamp · Utrecht University4 papers (2017–2019)Joppe Nieuwenhuis · Utrecht University4 papers (2017–2019) · 4 papers (2021–2024)Arjen Scholten · Utrecht University3 papers (2012–2014) · 3 papers (2017–2023)Elmer Stickel · Utrecht University3 papers (2017–2018)Anastassis Perrakis · University of York3 papers (2017–2022) · 3 papers (2017–2024) · 3 papers (2021–2022)Albert J. R. Heck · Utrecht University3 papers (2012–2014) · 2 papers (2021–2022)Pieter C. Van Breugel · Utrecht University2 papers (2015–2021)Oscar Krijgsman · The Netherlands Cancer Institute2 papers (2016–2022)Rui Lopes · Novartis (Switzerland)2 papers (2015–2021)Esther A. Zaal · Utrecht University2 papers (2021–2024) · 2 papers (2015–2021) · 2 papers (2017–2017)